gabexate has been researched along with Duodenal Ulcer in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, HY | 1 |
| Kim, JI | 1 |
| Park, YB | 1 |
| Cheung, DY | 1 |
| Cho, SH | 1 |
| Park, SH | 1 |
| Han, JY | 1 |
| Kim, JK | 1 |
1 other study available for gabexate and Duodenal Ulcer
| Article | Year |
|---|---|
The papilla of Vater just below the pylorus presenting as recurrent duodenal ulcer bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Bile; Bile Ducts; Duodenal Ulcer; | 2007 |